Dror, David M. - In: Risks : open access journal 13 (2025) 7, pp. 1-20
Capital investment in longevity science-research targeting the biological processes of aging through interventions like cellular reprogramming, AI-driven drug discovery, and biological age monitoring-may create significant divergence between traditional actuarial projections and emerging...